The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pseudoephedrine Market Research Report 2024
Synopsis
The global Pseudoephedrine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Pseudoephedrine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Pseudoephedrine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Pseudoephedrine in Sinusitis is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Pseudoephedrine include Pfizer (Wyeth), Endo International, Sanofi, Hanmi, Merck, Cypress Pharma, Johnson & Johnson, Kroger Company and CVS Caremark, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Pseudoephedrine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pseudoephedrine.
Report Scope
The Pseudoephedrine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pseudoephedrine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pseudoephedrine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer (Wyeth)
Endo International
Sanofi
Hanmi
Merck
Cypress Pharma
Johnson & Johnson
Kroger Company
CVS Caremark
Ratiopharm (Teva)
UCB, Inc
Pacific Pharmal
Sun Pharmaceutical
Apotec
Zhuhai Tianda Pharma
Sichuan Shenghe Pharmaceutical
Segment by Type
Active Pharmaceutical Ingredients
Preparation
Segment by Application
Sinusitis
Congestive Rhinitis
Bronchial Asthma
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pseudoephedrine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Pseudoephedrine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Pseudoephedrine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Pseudoephedrine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Pseudoephedrine in Sinusitis is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Pseudoephedrine include Pfizer (Wyeth), Endo International, Sanofi, Hanmi, Merck, Cypress Pharma, Johnson & Johnson, Kroger Company and CVS Caremark, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Pseudoephedrine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pseudoephedrine.
Report Scope
The Pseudoephedrine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pseudoephedrine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pseudoephedrine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer (Wyeth)
Endo International
Sanofi
Hanmi
Merck
Cypress Pharma
Johnson & Johnson
Kroger Company
CVS Caremark
Ratiopharm (Teva)
UCB, Inc
Pacific Pharmal
Sun Pharmaceutical
Apotec
Zhuhai Tianda Pharma
Sichuan Shenghe Pharmaceutical
Segment by Type
Active Pharmaceutical Ingredients
Preparation
Segment by Application
Sinusitis
Congestive Rhinitis
Bronchial Asthma
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pseudoephedrine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pseudoephedrine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Active Pharmaceutical Ingredients
1.2.3 Preparation
1.3 Market by Application
1.3.1 Global Pseudoephedrine Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Sinusitis
1.3.3 Congestive Rhinitis
1.3.4 Bronchial Asthma
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pseudoephedrine Market Perspective (2019-2030)
2.2 Pseudoephedrine Growth Trends by Region
2.2.1 Global Pseudoephedrine Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pseudoephedrine Historic Market Size by Region (2019-2024)
2.2.3 Pseudoephedrine Forecasted Market Size by Region (2025-2030)
2.3 Pseudoephedrine Market Dynamics
2.3.1 Pseudoephedrine Industry Trends
2.3.2 Pseudoephedrine Market Drivers
2.3.3 Pseudoephedrine Market Challenges
2.3.4 Pseudoephedrine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pseudoephedrine Players by Revenue
3.1.1 Global Top Pseudoephedrine Players by Revenue (2019-2024)
3.1.2 Global Pseudoephedrine Revenue Market Share by Players (2019-2024)
3.2 Global Pseudoephedrine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pseudoephedrine Revenue
3.4 Global Pseudoephedrine Market Concentration Ratio
3.4.1 Global Pseudoephedrine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pseudoephedrine Revenue in 2023
3.5 Pseudoephedrine Key Players Head office and Area Served
3.6 Key Players Pseudoephedrine Product Solution and Service
3.7 Date of Enter into Pseudoephedrine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pseudoephedrine Breakdown Data by Type
4.1 Global Pseudoephedrine Historic Market Size by Type (2019-2024)
4.2 Global Pseudoephedrine Forecasted Market Size by Type (2025-2030)
5 Pseudoephedrine Breakdown Data by Application
5.1 Global Pseudoephedrine Historic Market Size by Application (2019-2024)
5.2 Global Pseudoephedrine Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pseudoephedrine Market Size (2019-2030)
6.2 North America Pseudoephedrine Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pseudoephedrine Market Size by Country (2019-2024)
6.4 North America Pseudoephedrine Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pseudoephedrine Market Size (2019-2030)
7.2 Europe Pseudoephedrine Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pseudoephedrine Market Size by Country (2019-2024)
7.4 Europe Pseudoephedrine Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pseudoephedrine Market Size (2019-2030)
8.2 Asia-Pacific Pseudoephedrine Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pseudoephedrine Market Size by Region (2019-2024)
8.4 Asia-Pacific Pseudoephedrine Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pseudoephedrine Market Size (2019-2030)
9.2 Latin America Pseudoephedrine Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pseudoephedrine Market Size by Country (2019-2024)
9.4 Latin America Pseudoephedrine Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pseudoephedrine Market Size (2019-2030)
10.2 Middle East & Africa Pseudoephedrine Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pseudoephedrine Market Size by Country (2019-2024)
10.4 Middle East & Africa Pseudoephedrine Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer (Wyeth)
11.1.1 Pfizer (Wyeth) Company Detail
11.1.2 Pfizer (Wyeth) Business Overview
11.1.3 Pfizer (Wyeth) Pseudoephedrine Introduction
11.1.4 Pfizer (Wyeth) Revenue in Pseudoephedrine Business (2019-2024)
11.1.5 Pfizer (Wyeth) Recent Development
11.2 Endo International
11.2.1 Endo International Company Detail
11.2.2 Endo International Business Overview
11.2.3 Endo International Pseudoephedrine Introduction
11.2.4 Endo International Revenue in Pseudoephedrine Business (2019-2024)
11.2.5 Endo International Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Detail
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Pseudoephedrine Introduction
11.3.4 Sanofi Revenue in Pseudoephedrine Business (2019-2024)
11.3.5 Sanofi Recent Development
11.4 Hanmi
11.4.1 Hanmi Company Detail
11.4.2 Hanmi Business Overview
11.4.3 Hanmi Pseudoephedrine Introduction
11.4.4 Hanmi Revenue in Pseudoephedrine Business (2019-2024)
11.4.5 Hanmi Recent Development
11.5 Merck
11.5.1 Merck Company Detail
11.5.2 Merck Business Overview
11.5.3 Merck Pseudoephedrine Introduction
11.5.4 Merck Revenue in Pseudoephedrine Business (2019-2024)
11.5.5 Merck Recent Development
11.6 Cypress Pharma
11.6.1 Cypress Pharma Company Detail
11.6.2 Cypress Pharma Business Overview
11.6.3 Cypress Pharma Pseudoephedrine Introduction
11.6.4 Cypress Pharma Revenue in Pseudoephedrine Business (2019-2024)
11.6.5 Cypress Pharma Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Detail
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Pseudoephedrine Introduction
11.7.4 Johnson & Johnson Revenue in Pseudoephedrine Business (2019-2024)
11.7.5 Johnson & Johnson Recent Development
11.8 Kroger Company
11.8.1 Kroger Company Company Detail
11.8.2 Kroger Company Business Overview
11.8.3 Kroger Company Pseudoephedrine Introduction
11.8.4 Kroger Company Revenue in Pseudoephedrine Business (2019-2024)
11.8.5 Kroger Company Recent Development
11.9 CVS Caremark
11.9.1 CVS Caremark Company Detail
11.9.2 CVS Caremark Business Overview
11.9.3 CVS Caremark Pseudoephedrine Introduction
11.9.4 CVS Caremark Revenue in Pseudoephedrine Business (2019-2024)
11.9.5 CVS Caremark Recent Development
11.10 Ratiopharm (Teva)
11.10.1 Ratiopharm (Teva) Company Detail
11.10.2 Ratiopharm (Teva) Business Overview
11.10.3 Ratiopharm (Teva) Pseudoephedrine Introduction
11.10.4 Ratiopharm (Teva) Revenue in Pseudoephedrine Business (2019-2024)
11.10.5 Ratiopharm (Teva) Recent Development
11.11 UCB, Inc
11.11.1 UCB, Inc Company Detail
11.11.2 UCB, Inc Business Overview
11.11.3 UCB, Inc Pseudoephedrine Introduction
11.11.4 UCB, Inc Revenue in Pseudoephedrine Business (2019-2024)
11.11.5 UCB, Inc Recent Development
11.12 Pacific Pharmal
11.12.1 Pacific Pharmal Company Detail
11.12.2 Pacific Pharmal Business Overview
11.12.3 Pacific Pharmal Pseudoephedrine Introduction
11.12.4 Pacific Pharmal Revenue in Pseudoephedrine Business (2019-2024)
11.12.5 Pacific Pharmal Recent Development
11.13 Sun Pharmaceutical
11.13.1 Sun Pharmaceutical Company Detail
11.13.2 Sun Pharmaceutical Business Overview
11.13.3 Sun Pharmaceutical Pseudoephedrine Introduction
11.13.4 Sun Pharmaceutical Revenue in Pseudoephedrine Business (2019-2024)
11.13.5 Sun Pharmaceutical Recent Development
11.14 Apotec
11.14.1 Apotec Company Detail
11.14.2 Apotec Business Overview
11.14.3 Apotec Pseudoephedrine Introduction
11.14.4 Apotec Revenue in Pseudoephedrine Business (2019-2024)
11.14.5 Apotec Recent Development
11.15 Zhuhai Tianda Pharma
11.15.1 Zhuhai Tianda Pharma Company Detail
11.15.2 Zhuhai Tianda Pharma Business Overview
11.15.3 Zhuhai Tianda Pharma Pseudoephedrine Introduction
11.15.4 Zhuhai Tianda Pharma Revenue in Pseudoephedrine Business (2019-2024)
11.15.5 Zhuhai Tianda Pharma Recent Development
11.16 Sichuan Shenghe Pharmaceutical
11.16.1 Sichuan Shenghe Pharmaceutical Company Detail
11.16.2 Sichuan Shenghe Pharmaceutical Business Overview
11.16.3 Sichuan Shenghe Pharmaceutical Pseudoephedrine Introduction
11.16.4 Sichuan Shenghe Pharmaceutical Revenue in Pseudoephedrine Business (2019-2024)
11.16.5 Sichuan Shenghe Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Pseudoephedrine Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Active Pharmaceutical Ingredients
Table 3. Key Players of Preparation
Table 4. Global Pseudoephedrine Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Pseudoephedrine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Pseudoephedrine Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Pseudoephedrine Market Share by Region (2019-2024)
Table 8. Global Pseudoephedrine Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Pseudoephedrine Market Share by Region (2025-2030)
Table 10. Pseudoephedrine Market Trends
Table 11. Pseudoephedrine Market Drivers
Table 12. Pseudoephedrine Market Challenges
Table 13. Pseudoephedrine Market Restraints
Table 14. Global Pseudoephedrine Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Pseudoephedrine Market Share by Players (2019-2024)
Table 16. Global Top Pseudoephedrine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pseudoephedrine as of 2023)
Table 17. Ranking of Global Top Pseudoephedrine Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Pseudoephedrine Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Pseudoephedrine Product Solution and Service
Table 21. Date of Enter into Pseudoephedrine Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Pseudoephedrine Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Pseudoephedrine Revenue Market Share by Type (2019-2024)
Table 25. Global Pseudoephedrine Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Pseudoephedrine Revenue Market Share by Type (2025-2030)
Table 27. Global Pseudoephedrine Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Pseudoephedrine Revenue Market Share by Application (2019-2024)
Table 29. Global Pseudoephedrine Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Pseudoephedrine Revenue Market Share by Application (2025-2030)
Table 31. North America Pseudoephedrine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Pseudoephedrine Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Pseudoephedrine Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Pseudoephedrine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Pseudoephedrine Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Pseudoephedrine Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Pseudoephedrine Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Pseudoephedrine Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Pseudoephedrine Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Pseudoephedrine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Pseudoephedrine Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Pseudoephedrine Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Pseudoephedrine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Pseudoephedrine Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Pseudoephedrine Market Size by Country (2025-2030) & (US$ Million)
Table 46. Pfizer (Wyeth) Company Detail
Table 47. Pfizer (Wyeth) Business Overview
Table 48. Pfizer (Wyeth) Pseudoephedrine Product
Table 49. Pfizer (Wyeth) Revenue in Pseudoephedrine Business (2019-2024) & (US$ Million)
Table 50. Pfizer (Wyeth) Recent Development
Table 51. Endo International Company Detail
Table 52. Endo International Business Overview
Table 53. Endo International Pseudoephedrine Product
Table 54. Endo International Revenue in Pseudoephedrine Business (2019-2024) & (US$ Million)
Table 55. Endo International Recent Development
Table 56. Sanofi Company Detail
Table 57. Sanofi Business Overview
Table 58. Sanofi Pseudoephedrine Product
Table 59. Sanofi Revenue in Pseudoephedrine Business (2019-2024) & (US$ Million)
Table 60. Sanofi Recent Development
Table 61. Hanmi Company Detail
Table 62. Hanmi Business Overview
Table 63. Hanmi Pseudoephedrine Product
Table 64. Hanmi Revenue in Pseudoephedrine Business (2019-2024) & (US$ Million)
Table 65. Hanmi Recent Development
Table 66. Merck Company Detail
Table 67. Merck Business Overview
Table 68. Merck Pseudoephedrine Product
Table 69. Merck Revenue in Pseudoephedrine Business (2019-2024) & (US$ Million)
Table 70. Merck Recent Development
Table 71. Cypress Pharma Company Detail
Table 72. Cypress Pharma Business Overview
Table 73. Cypress Pharma Pseudoephedrine Product
Table 74. Cypress Pharma Revenue in Pseudoephedrine Business (2019-2024) & (US$ Million)
Table 75. Cypress Pharma Recent Development
Table 76. Johnson & Johnson Company Detail
Table 77. Johnson & Johnson Business Overview
Table 78. Johnson & Johnson Pseudoephedrine Product
Table 79. Johnson & Johnson Revenue in Pseudoephedrine Business (2019-2024) & (US$ Million)
Table 80. Johnson & Johnson Recent Development
Table 81. Kroger Company Company Detail
Table 82. Kroger Company Business Overview
Table 83. Kroger Company Pseudoephedrine Product
Table 84. Kroger Company Revenue in Pseudoephedrine Business (2019-2024) & (US$ Million)
Table 85. Kroger Company Recent Development
Table 86. CVS Caremark Company Detail
Table 87. CVS Caremark Business Overview
Table 88. CVS Caremark Pseudoephedrine Product
Table 89. CVS Caremark Revenue in Pseudoephedrine Business (2019-2024) & (US$ Million)
Table 90. CVS Caremark Recent Development
Table 91. Ratiopharm (Teva) Company Detail
Table 92. Ratiopharm (Teva) Business Overview
Table 93. Ratiopharm (Teva) Pseudoephedrine Product
Table 94. Ratiopharm (Teva) Revenue in Pseudoephedrine Business (2019-2024) & (US$ Million)
Table 95. Ratiopharm (Teva) Recent Development
Table 96. UCB, Inc Company Detail
Table 97. UCB, Inc Business Overview
Table 98. UCB, Inc Pseudoephedrine Product
Table 99. UCB, Inc Revenue in Pseudoephedrine Business (2019-2024) & (US$ Million)
Table 100. UCB, Inc Recent Development
Table 101. Pacific Pharmal Company Detail
Table 102. Pacific Pharmal Business Overview
Table 103. Pacific Pharmal Pseudoephedrine Product
Table 104. Pacific Pharmal Revenue in Pseudoephedrine Business (2019-2024) & (US$ Million)
Table 105. Pacific Pharmal Recent Development
Table 106. Sun Pharmaceutical Company Detail
Table 107. Sun Pharmaceutical Business Overview
Table 108. Sun Pharmaceutical Pseudoephedrine Product
Table 109. Sun Pharmaceutical Revenue in Pseudoephedrine Business (2019-2024) & (US$ Million)
Table 110. Sun Pharmaceutical Recent Development
Table 111. Apotec Company Detail
Table 112. Apotec Business Overview
Table 113. Apotec Pseudoephedrine Product
Table 114. Apotec Revenue in Pseudoephedrine Business (2019-2024) & (US$ Million)
Table 115. Apotec Recent Development
Table 116. Zhuhai Tianda Pharma Company Detail
Table 117. Zhuhai Tianda Pharma Business Overview
Table 118. Zhuhai Tianda Pharma Pseudoephedrine Product
Table 119. Zhuhai Tianda Pharma Revenue in Pseudoephedrine Business (2019-2024) & (US$ Million)
Table 120. Zhuhai Tianda Pharma Recent Development
Table 121. Sichuan Shenghe Pharmaceutical Company Detail
Table 122. Sichuan Shenghe Pharmaceutical Business Overview
Table 123. Sichuan Shenghe Pharmaceutical Pseudoephedrine Product
Table 124. Sichuan Shenghe Pharmaceutical Revenue in Pseudoephedrine Business (2019-2024) & (US$ Million)
Table 125. Sichuan Shenghe Pharmaceutical Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pseudoephedrine Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Pseudoephedrine Market Share by Type: 2023 VS 2030
Figure 3. Active Pharmaceutical Ingredients Features
Figure 4. Preparation Features
Figure 5. Global Pseudoephedrine Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Pseudoephedrine Market Share by Application: 2023 VS 2030
Figure 7. Sinusitis Case Studies
Figure 8. Congestive Rhinitis Case Studies
Figure 9. Bronchial Asthma Case Studies
Figure 10. Other Case Studies
Figure 11. Pseudoephedrine Report Years Considered
Figure 12. Global Pseudoephedrine Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Pseudoephedrine Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Pseudoephedrine Market Share by Region: 2023 VS 2030
Figure 15. Global Pseudoephedrine Market Share by Players in 2023
Figure 16. Global Top Pseudoephedrine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pseudoephedrine as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Pseudoephedrine Revenue in 2023
Figure 18. North America Pseudoephedrine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Pseudoephedrine Market Share by Country (2019-2030)
Figure 20. United States Pseudoephedrine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Pseudoephedrine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Pseudoephedrine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Pseudoephedrine Market Share by Country (2019-2030)
Figure 24. Germany Pseudoephedrine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Pseudoephedrine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Pseudoephedrine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Pseudoephedrine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Pseudoephedrine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Pseudoephedrine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Pseudoephedrine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Pseudoephedrine Market Share by Region (2019-2030)
Figure 32. China Pseudoephedrine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Pseudoephedrine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Pseudoephedrine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Pseudoephedrine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Pseudoephedrine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Pseudoephedrine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Pseudoephedrine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Pseudoephedrine Market Share by Country (2019-2030)
Figure 40. Mexico Pseudoephedrine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Pseudoephedrine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Pseudoephedrine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Pseudoephedrine Market Share by Country (2019-2030)
Figure 44. Turkey Pseudoephedrine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Pseudoephedrine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Pfizer (Wyeth) Revenue Growth Rate in Pseudoephedrine Business (2019-2024)
Figure 47. Endo International Revenue Growth Rate in Pseudoephedrine Business (2019-2024)
Figure 48. Sanofi Revenue Growth Rate in Pseudoephedrine Business (2019-2024)
Figure 49. Hanmi Revenue Growth Rate in Pseudoephedrine Business (2019-2024)
Figure 50. Merck Revenue Growth Rate in Pseudoephedrine Business (2019-2024)
Figure 51. Cypress Pharma Revenue Growth Rate in Pseudoephedrine Business (2019-2024)
Figure 52. Johnson & Johnson Revenue Growth Rate in Pseudoephedrine Business (2019-2024)
Figure 53. Kroger Company Revenue Growth Rate in Pseudoephedrine Business (2019-2024)
Figure 54. CVS Caremark Revenue Growth Rate in Pseudoephedrine Business (2019-2024)
Figure 55. Ratiopharm (Teva) Revenue Growth Rate in Pseudoephedrine Business (2019-2024)
Figure 56. UCB, Inc Revenue Growth Rate in Pseudoephedrine Business (2019-2024)
Figure 57. Pacific Pharmal Revenue Growth Rate in Pseudoephedrine Business (2019-2024)
Figure 58. Sun Pharmaceutical Revenue Growth Rate in Pseudoephedrine Business (2019-2024)
Figure 59. Apotec Revenue Growth Rate in Pseudoephedrine Business (2019-2024)
Figure 60. Zhuhai Tianda Pharma Revenue Growth Rate in Pseudoephedrine Business (2019-2024)
Figure 61. Sichuan Shenghe Pharmaceutical Revenue Growth Rate in Pseudoephedrine Business (2019-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
